CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1999; 49:138
doi: 10.3322/canjclin.49.3.138
© 1999 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mettlin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mettlin, C.

CA: A Cancer Journal for Clinicians, Vol 49, Issue 3 138-144, Copyright © 1999 by American Cancer Society

ARTICLES

Global breast cancer mortality statistics

C. Mettlin
Roswell Park Cancer Institute, Buffalo, NY, USA.

Breast cancer mortality is declining in the United States, as well as in certain other industrialized areas--such as Canada, Austria, Germany, and the United Kingdom--possibly due to increased utilization of mammographic screening, early detection of disease, and availability of improved therapies. At least some of the decline has been attributed, however, to the higher fertility rates of the cohort of women born between 1924 and 1938 who bore children during the post-World War II period. In contrast, certain European nations--Spain, Portugal, Greece, Hungary, Poland, and Italy--have not reported these favorable trends. The lowest breast cancer mortality rates are reported in Asian regions, leading researchers to speculate that dietary, cultural, and/or environmental factors might be implicated in the etiology of the disease.


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Y. Shen, D.-K. Li, J. Wu, Z. Zhang, and E. Gao
Joint Effects of the CYP1A1 MspI, ER{alpha} PvuII, and ER{alpha} XbaI Polymorphisms on the Risk of Breast Cancer: Results from a Population-Based Case-Control Study in Shanghai, China.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 342 - 347.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. Cianfrocca and W. J. Gradishar
Controversies in the Therapy of Early Stage Breast Cancer
Oncologist, November 1, 2005; 10(10): 766 - 779.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Zielinski, S. Beslija, Z. Mrsic-Krmpotic, M. Welnicka-Jaskiewicz, C. Wiltschke, Z. Kahan, M. Grgic, V. Tzekova, M. Inbar, J. Cervek, et al.
Gemcitabine, Epirubicin, and Paclitaxel Versus Fluorouracil, Epirubicin, and Cyclophosphamide As First-Line Chemotherapy in Metastatic Breast Cancer: A Central European Cooperative Oncology Group International, Multicenter, Prospective, Randomized Phase III Trial
J. Clin. Oncol., March 1, 2005; 23(7): 1401 - 1408.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
K. Lutchman Singh, M. Davies, and R. Chatterjee
Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing
Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
P. MUTI
The Role of Endogenous Hormones in the Etiology and Prevention of Breast Cancer: The Epidemiological Evidence
Ann. N.Y. Acad. Sci., December 1, 2004; 1028(1): 273 - 282.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. Cianfrocca and L. J. Goldstein
Prognostic and Predictive Factors in Early-Stage Breast Cancer
Oncologist, November 1, 2004; 9(6): 606 - 616.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
I. Khalkhali, J. K. Baum, J. Villanueva-Meyer, S. L. Edell, L. G. Hanelin, C. E. Lugo, R. Taillefer, L. M. Freeman, C. E. Neal, A. M. Scheff, et al.
99mTc Sestamibi Breast Imaging for the Examination of Patients with Dense and Fatty Breasts: Multicenter Study
Radiology, January 1, 2002; 222(1): 149 - 155.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Kawamori, N. Uchiya, S. Nakatsugi, K. Watanabe, S. Ohuchida, H. Yamamoto, T. Maruyama, K. Kondo, T. Sugimura, and K. Wakabayashi
Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development
Carcinogenesis, December 1, 2001; 22(12): 2001 - 2004.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Schwartsmann
Breast Cancer in South America: Challenges to Improve Early Detection and Medical Management of a Public Health Problem
J. Clin. Oncol., September 15, 2001; 19(90001): 118s - 124.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
I. Hilger, W. Andrä, R. Hergt, R. Hiergeist, H. Schubert, and W. A. Kaiser
Electromagnetic Heating of Breast Tumors in Interventional Radiology: In Vitro and in Vivo Studies in Human Cadavers and Mice
Radiology, February 1, 2001; 218(2): 570 - 575.
[Abstract] [Full Text]

Home page
 J Natl Cancer Inst MonogrHome page
J. Russo, Y.-F. Hu, X. Yang, and I. H. Russo
Chapter 1: Developmental, Cellular, and Molecular Basis of Human Breast Cancer
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 17 - 37.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by American Cancer Society.